Assuring Clonality on the Beacon Digital Cell Line Development Platform

Kim Le1, Christopher Tan1, Huong Le1

  • 1Drug Substance Technologies, Process Development, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, CA, 91320, USA.

Biotechnology Journal
|November 20, 2019
PubMed